Skip to main content
. Author manuscript; available in PMC: 2018 Oct 18.
Published in final edited form as: Psychopharmacology (Berl). 2018 Aug 16;235(10):3017–3030. doi: 10.1007/s00213-018-4992-7

Fig. 1.

Fig. 1

a Heat map shows the top 50 most significantly differently changed metabolites between ketamine and placebo over time among healthy controls (without major depressive disorder). Rows indicate standardized mean of log-transformed metabolite by treatment group and time. The dendrogram from hierarchical clustering indicates groups of metabolites with similar treatment and time profiles. b Heat map shows the top 50 most significantly differently changed metabolites between ketamine and placebo over time among participants with major depressive disorder. Rows indicate standardized mean of log-transformed metabolite by treatment group and time. The dendrogram from hierarchical clustering indicates groups of metabolites with similar treatment and time profiles